FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Krengli, Marco ^a,b   Milia, Maria E ^a   Turri, Lucia ^a   Mones, Eleonora ^a   Bassi, Maria C ^a   Cannillo, Barbara ^a   Deantonio, Letizia ^a   Sacchetti, Gianmauro ^a   Brambilla, Marco ^a   Inglese, Eugenio ^a  

^a University Hospital Maggiore della Carita   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; MITOMYCIN C; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; BASAL CELL CARCINOMA; CANCER PALLIATIVE THERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CLOACOGENIC CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; RECTUM BIOPSY; RECTUM CARCINOMA; SIMULATION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME; ANUS TUMOR; CARCINOMA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77952514437     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-10     Document Type: Article

References (19)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. 2002, VIII. IARC Scientific Publication No. 155, Lyons: International Agency for Research on Cancer.
2. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004, 101:281-288. 10.1002/cncr.20364, 15241824.
3. Nigro ND, Vaitkevicius VK, Considine B. Combined therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum 1974, 17:354-356. 10.1007/BF02586980, 4830803.
4. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996, 348:1049-1054. 10.1016/S0140-6736(96)03409-5, 8874455.
5. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997, 15:2040-2049.
6. Nguyen BT, Joon DL, Khoo V, Quong G, Chao M, Wada M, Joon ML, See A, Feigen M, Rykers K, Kai C, Zupan E, Scott A. Assessing the impact of FDG-PET in the management of anal cancer. Radiother Oncol 2008, 87:376-382. 10.1016/j.radonc.2008.04.003, 18453023.
7. Myerson RJ, Kong F, Birnbaum EH, Fleshman JW, Kodner IJ, Picus J, Ratkin GA, Read TE, Walz BJ. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 2001, 61:15-22. 10.1016/S0167-8140(01)00404-2, 11578724.
8. Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, Das P, Gunderson LL, Hong TS, Kim JJ, Willett CG, Kachnic LA. Elective clinical target volumes for conformal therapy in anorectal cancer: an Radiation Therapy Oncology Group Consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 2009, 74:824-830.
9. Trautmann TG, Zuger JH. Positron Emission Tomography for pre-treatment staging and posttreatment evaluation in cancer of the anal canal. Mol Imaging Biol 2005, 7:309-313. 10.1007/s11307-005-0003-6, 16028002.
10. Cotter SE, Grigsby PW, Siegel BA, Dehdashti F, Malyapa RS, Fleshman JW, Birnbaum EH, Wang X, Abbey E, Tan B, Kodner IJ, Hunt SR, Lowney JK, Mutch MG, Dietz DW, Myerson RJ. PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 2006, 65:720-725.
11. Anderson C, Koshy M, Staley C, Esiashvili N, Ghavidel S, Fowler Z, Fox T, Esteves F, Landry J, Godette K. PET-CT fusion in radiation management of patients with anorectal tumors. Int J Radiat Oncol Biol Phys 2007, 69:155-162.
12. Schwarz JK, Siegel BA, Dehdashti F, Myerson RJ, Fleshman JW, Grigsby PW. Tumor response and survival predicted by posttherapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys 2008, 71:180-186.
13. Winton E, Heriot AG, Ng M, Hicks RJ, Hogg A, Milner A, Leong T, Fay M, MacKay J, Drummond E, Ngan SY. The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer 2009, 100:693-700. 10.1038/sj.bjc.6604897, 19259091.
14. Bassi MC, Turri L, Sacchetti G, Loi G, Cannillo B, La Mattina P, Brambilla M, Inglese E, Krengli M. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 2008, 70:1423-1426.
15. O'Neill BD, Salerno G, Thomas K, Tait DM, Brown G. MR versus CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy. Br J Radiol 2009, 82:509-513. 10.1259/bjr/60198873, 19153180.
16. Mai SK, Welzel G, Hermann B, Wenz F, Haberkorn U, Dinter DJ. Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?. Strahlenther Onkol 2009, 185:254-259. 10.1007/s00066-009-1944-5, 19370429.
17. Ciernik IF, Huser M, Burger C, Davis B, Szekely G. Automated functional image-guided radiation treatment planning for rectal cancer. Int J Radiat Oncol Biol Phys 2005, 62:893-900.
18. Patel DA, Chang ST, Goodman KA, Quon A, Thorndyke B, Gambhir SS, McMillan A, Loo BW, Koong AC. Impact of integrated PET/CT on variability of target volume delineation in rectal cancer. Technol Cancer Res Treat 2007, 6:31-36.
19. Brambilla M, Matheoud R, Secco C, Loi G, Krengli M, Inglese E. Impact of target-to-background ratio and target size on threshold segmentation for PET target volume delineation in radiation treatment planning. Med Phys 2008, 35:1207-1213. 10.1118/1.2870215, 18491512.